Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio
Pivotal bioVenture Partners Investment Advisor LLC Performance:
2025 Q4: 28.06%YTD: 25.79%2024: 20.98%
Performance for 2025 Q4 is 28.06%, and YTD is 25.79%, and 2024 is 20.98%.
About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings
On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $258.7 Millions as of 31 Dec, 2025.
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , ARQT. The fund has invested 24.5% of it's portfolio in VAXCYTE INC and 17.7% of portfolio in OCULIS HOLDING AG.
They significantly reduced their stock positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT) and ZENAS BIOPHARMA INC. Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in EVOMMUNE INC. The fund showed a lot of confidence in some stocks as they added substantially to IMMUNOME INC (IMNM).
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , ARQT. The fund has invested 24.5% of it's portfolio in VAXCYTE INC and 17.7% of portfolio in OCULIS HOLDING AG.
They significantly reduced their stock positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT) and ZENAS BIOPHARMA INC. Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in EVOMMUNE INC. The fund showed a lot of confidence in some stocks as they added substantially to IMMUNOME INC (IMNM).
Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of 28.06% in the last quarter. In trailing 12 months, it's portfolio return was 25.79%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| evommune inc | 32,989,300 |
| maplight therapeutics inc | 10,743,100 |
New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC
Additions
| Ticker | % Inc. |
|---|---|
| immunome inc | 45.77 |
Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC
Reductions
| Ticker | % Reduced |
|---|---|
| arcutis biotherapeutics inc | -35.55 |
| zenas biopharma inc | -24.01 |
| oculis holding ag | -0.53 |
Pivotal bioVenture Partners Investment Advisor LLC reduced stake in above stock
Sold off
Sector Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 53.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 53.8 |
| Others | 46.2 |
Market Cap. Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 46.2 |
| MID-CAP | 45.9 |
| SMALL-CAP | 7 |
Stocks belong to which Index?
About 47.5% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 52.5 |
| RUSSELL 2000 | 47.5 |
Pivotal bioVenture Partners Investment Advisor LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC has 12 stocks in it's portfolio. RXRX proved to be the most loss making stock for the portfolio. ARQT was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.
Last Reported on: 13 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ARQT | arcutis biotherapeutics inc | 15.34 | 1,366,620 | 39,686,800 | reduced | -35.55 | ||
| BOLT | bolt biotherapeutics inc | 0.20 | 94,573 | 517,125 | unchanged | 0.00 | ||
| IMNM | immunome inc | 6.08 | 732,512 | 15,734,400 | added | 45.77 | ||
| PCVX | vaxcyte inc | 24.48 | 1,372,420 | 63,323,700 | unchanged | 0.00 | ||
| RLYB | rallybio corp | 0.64 | 300,580 | 1,649,590 | unchanged | 0.00 | ||
| RXRX | recursion pharmaceuticals in | 0.94 | 595,518 | 2,435,670 | unchanged | 0.00 | ||
| TRVI | trevi therapeutics inc | 6.08 | 1,256,780 | 15,734,900 | unchanged | 0.00 | ||
| oculis holding ag | 17.67 | 2,288,660 | 45,704,500 | reduced | -0.53 | |||
| evommune inc | 12.75 | 1,926,940 | 32,989,300 | new | ||||
| zenas biopharma inc | 8.31 | 591,991 | 21,495,200 | reduced | -24.01 | |||
| maplight therapeutics inc | 4.15 | 611,447 | 10,743,100 | new | ||||
| bioage labs inc | 3.34 | 653,374 | 8,644,140 | unchanged | 0.00 | |||